FAM3D Inhibitors
FAM3D Inhibitors are a diverse group of chemical compounds that lead to the diminished functional activity of FAM3D by targeting various biochemical and cellular pathways. Alloxan and Sodium (meta)arsenite exert their inhibitory effects by inducing oxidative stress, which can modify or damage the protein structure of FAM3D, leading to its decreased functionality. Likewise, Lithium Chloride's inhibition of GSK-3 may alter cellular signaling in a manner that reduces FAM3D activity, while PD 98059 and LY 294002 target the MAPK/ERK and PI3K/AKT pathways, respectively, which could have downstream effects that diminish the protein's function. Rapamycin and SB 203580, by modulating the mTOR and p38 MAPK pathways, have the potential to indirectly affect FAM3D's activity, particularly if it is involved in processes regulated by these pathways, such as protein synthesis, cellular metabolism, and inflammatoryresponses.
Chemicals such as Sulindac Sulfide and Brefeldin A target prostaglandin synthesis and Golgi apparatus function, respectively. Sulindac Sulfide's impact on prostaglandin pathways could lead to an environment less conducive to FAM3D activity if it is associated with these lipid mediators, while Brefeldin A may disrupt FAM3D's processing or secretion, which is critical for its function. Tunicamycin, by inhibiting N-linked glycosylation, could affect FAM3D's structure and function if glycosylation is necessary for its activity. Thapsigargin and 2-Deoxy-D-glucose challenge cellular homeostasis and energy metabolism by interfering with calcium regulation and glycolysis, respectively. The inhibition of SERCA by Thapsigargin can lead to altered calcium-dependent signaling pathways, which may impact FAM3D's activity if it is calcium-responsive. Simultaneously, 2-Deoxy-D-glucose's restriction on energy production could reduce the availability of ATP necessary for FAM3D's optimal function, assuming that FAM3D relies on glycolytic ATP. Collectively, these inhibitors operate through distinct mechanisms but converge on the common outcome of diminishing the functional activity of FAM3D within the cell.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Alloxan monohydrate | 2244-11-3 | sc-254940 | 10 g | $54.00 | ||
Alloxan induces oxidative stress by generating reactive oxygen species (ROS). Elevated ROS levels can damage cellular components, including proteins. This oxidative stress potentially diminishes the activity of FAM3D by altering its structure or function. | ||||||
Sodium (meta)arsenite | 7784-46-5 | sc-250986 sc-250986A | 100 g 1 kg | $108.00 $780.00 | 3 | |
Sodium (meta)arsenite disrupts cellular redox balance by increasing ROS. This oxidative stress can lead to the oxidation of specific amino acids in proteins, potentially leading to the diminished functionality of FAM3D. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium Chloride inhibits glycogen synthase kinase 3 (GSK-3). Since GSK-3 is involved in various signaling pathways, its inhibition might lead to altered cellular responses that indirectly diminish the activity of FAM3D. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD 98059 is a MEK inhibitor that interferes with the MAPK/ERK pathway. This interference could lead to the alteration of downstream signaling events, potentially diminishing the activity of FAM3D as a consequence. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY 294002 is a PI3K inhibitor which may disrupt AKT signaling. Since AKT is involved in various cellular processes, inhibition of this pathway could indirectly diminish the activity of FAM3D by affecting related signaling cascades. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR pathway, which could alter protein synthesis and cellular metabolism. This inhibition may lead to an indirect decrease in FAM3D functionality by impacting cellular processes where FAM3D is involved. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB 203580 is a p38 MAPK inhibitor that could affect inflammatory signaling pathways. This could lead to an indirect diminishment of FAM3D activity if FAM3D is involved in processes modulated by p38 MAPK. | ||||||
Sulindac | 38194-50-2 | sc-202823 sc-202823A sc-202823B | 1 g 5 g 10 g | $32.00 $86.00 $150.00 | 3 | |
Sulindac Sulfide is a cyclooxygenase inhibitor that impacts prostaglandin synthesis. By inhibiting this pathway, it could indirectly diminish FAM3D's activity if FAM3D is linked to pathways modulated by prostaglandins. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Brefeldin A disrupts Golgi apparatus function and protein trafficking. If FAM3D requires proper Golgi-mediated processing or secretion, Brefeldin A could indirectly diminish its activity by impairing this cellular process. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $172.00 $305.00 | 66 | |
Tunicamycin inhibits N-linked glycosylation. If FAM3D undergoes glycosylation for its proper function, tunicamycin could diminish its activity by preventing this post-translational modification. | ||||||